Showing results (1061-1070 of 1,205) with videos related to

Sort By:
Pageof 121
JAMA Surgery|December 17, 2025
Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine TumorsMarco Ventin, Shahrzad Arya, Liti Zhang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 13, 2002
Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern ChinaL Dong Wang, W Bin Yue, Y Zhou, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Nature|May 15, 2024
Entanglement of nanophotonic quantum memory nodes in a telecom networkC M Knaut, A Suleymanzade, Y-C Wei, et al.
Blood Advances|February 5, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter's transformationKatharine Louise Lewis, Sarit E Assouline, Ross Ian Baker, et al.
Annals of Surgery|November 18, 2021
Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and SurvivalBrett L Ecker, Paul Shin, Lily V Saadat, et al.
BMJ Open|February 25, 2022
Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trialPaul Jack Karanicolas, Yulia Lin, Stuart McCluskey, et al.
Blood|December 4, 2023
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomasStephen J Schuster, Ling-Yuh Huw, Christopher R Bolen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunctionW Reid, M Sadowska, F Denaro, et al.
Journal of the National Cancer Institute|February 14, 2022
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery ConsortiumQuisette P Janssen, Jacob L van Dam, Deesje Doppenberg, et al.
Pageof 121